Cerebrospinal fluid (CSF) biomarkerssuch as amyloid β1–42 (Aβ1–42), total tau(T-tau), and phosphorylated tau181 (P-tau181) levels are core biomarkersfor early diagnosis of AD. The gene discussed is MAPT; the disease is Alzheimer disease.